Healthpeak Properties, Inc. to Post Q2 2023 Earnings of $0.44 Per Share, Jefferies Financial Group Forecasts (NYSE:PEAK)

Posted by on May 4th, 2023

Healthpeak Properties, Inc. (NYSE:PEAK – Get Rating) – Stock analysts at Jefferies Financial Group boosted their Q2 2023 earnings per share (EPS) estimates for Healthpeak Properties in a research report issued to clients and investors on Monday, May 1st. Jefferies Financial Group analyst J. Petersen now forecasts that the company will earn $0.44 per share for the quarter, up from their prior forecast of $0.43. The consensus estimate for Healthpeak Properties’ current full-year earnings is $1.73 per share. Jefferies Financial Group also issued estimates for Healthpeak Properties’ Q4 2023 earnings at $0.45 EPS, FY2024 earnings at $1.82 EPS, FY2025 earnings at $1.95 EPS and FY2026 earnings at $1.94 EPS.

Healthpeak Properties (NYSE:PEAK – Get Rating) last announced its earnings results on Tuesday, February 7th. The company reported $0.01 EPS for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.42). The business had revenue of $524.47 million for the quarter, compared to the consensus estimate of $518.85 million. Healthpeak Properties had a net margin of 26.17% and a return on equity of 7.76%. Healthpeak Properties’s revenue was up 8.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.41 EPS.

PEAK has been the subject of a number of other research reports. Stifel Nicolaus decreased their price objective on Healthpeak Properties from $34.00 to $30.00 in a report on Friday, April 28th. Scotiabank cut Healthpeak Properties from a “sector outperform” rating to a “sector perform” rating and set a $24.00 target price on the stock. in a research note on Friday, March 31st. Citigroup lowered Healthpeak Properties from a “buy” rating to a “neutral” rating and set a $23.00 price target for the company. in a research report on Wednesday, April 5th. Mizuho upgraded shares of Healthpeak Properties from a “neutral” rating to a “buy” rating and dropped their price target for the stock from $29.00 to $25.00 in a research note on Monday, April 24th. Finally, Barclays reduced their price objective on shares of Healthpeak Properties from $34.00 to $33.00 and set an “overweight” rating for the company in a research note on Friday, February 10th. Seven research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat, Healthpeak Properties currently has a consensus rating of “Hold” and a consensus target price of $27.77.

Healthpeak Properties Price Performance

PEAK opened at $21.28 on Wednesday. The stock has a fifty day simple moving average of $21.88 and a two-hundred day simple moving average of $24.22. The company has a current ratio of 0.72, a quick ratio of 0.72 and a debt-to-equity ratio of 0.90. The company has a market cap of $11.64 billion, a price-to-earnings ratio of 21.07, a price-to-earnings-growth ratio of 3.13 and a beta of 0.89. Healthpeak Properties has a 12-month low of $20.21 and a 12-month high of $33.42.

Healthpeak Properties Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, May 19th. Investors of record on Monday, May 8th will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 5.64%. The ex-dividend date of this dividend is Friday, May 5th. Healthpeak Properties’s dividend payout ratio is currently 118.81%.

Insiders Place Their Bets

In other news, Director Sara Grootwassink Lewis purchased 4,000 shares of the stock in a transaction dated Wednesday, March 15th. The shares were purchased at an average cost of $21.43 per share, with a total value of $85,720.00. Following the acquisition, the director now directly owns 4,000 shares of the company’s stock, valued at $85,720. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, Director Sara Grootwassink Lewis purchased 4,000 shares of the business’s stock in a transaction on Wednesday, March 15th. The stock was acquired at an average cost of $21.43 per share, for a total transaction of $85,720.00. Following the purchase, the director now directly owns 4,000 shares in the company, valued at approximately $85,720. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Scott M. Brinker acquired 16,300 shares of the stock in a transaction dated Thursday, March 2nd. The stock was acquired at an average price of $23.63 per share, for a total transaction of $385,169.00. Following the purchase, the chief executive officer now directly owns 206,525 shares in the company, valued at $4,880,185.75. The disclosure for this purchase can be found here. In the last quarter, insiders purchased 21,817 shares of company stock valued at $506,099. Company insiders own 0.19% of the company’s stock.

Institutional Investors Weigh In On Healthpeak Properties

A number of hedge funds have recently modified their holdings of the business. SG Americas Securities LLC raised its stake in shares of Healthpeak Properties by 362.5% in the fourth quarter. SG Americas Securities LLC now owns 58,214 shares of the company’s stock worth $1,459,000 after buying an additional 45,628 shares during the period. EverSource Wealth Advisors LLC raised its stake in shares of Healthpeak Properties by 270.8% in the third quarter. EverSource Wealth Advisors LLC now owns 1,294 shares of the company’s stock worth $30,000 after buying an additional 945 shares during the period. Macquarie Group Ltd. raised its stake in shares of Healthpeak Properties by 26.4% in the third quarter. Macquarie Group Ltd. now owns 2,216,061 shares of the company’s stock worth $51,084,000 after buying an additional 462,731 shares during the period. Asset Management One Co. Ltd. raised its stake in shares of Healthpeak Properties by 7.0% in the fourth quarter. Asset Management One Co. Ltd. now owns 1,215,167 shares of the company’s stock worth $30,621,000 after buying an additional 79,931 shares during the period. Finally, Zacks Investment Management raised its stake in shares of Healthpeak Properties by 3.6% in the third quarter. Zacks Investment Management now owns 1,131,858 shares of the company’s stock worth $25,943,000 after buying an additional 39,622 shares during the period. Institutional investors own 92.04% of the company’s stock.

Healthpeak Properties Company Profile

(Get Rating)

Healthpeak Properties, Inc is a real estate investment trust, which engages in the acquisition, development, ownership, and management of healthcare real estate. It operates through the following business segments: Life Science, Medical Office and Continuing Care Retirement Community (CCRC). The Life Science segment contains laboratory and office space primarily for biotechnology, medical device and pharmaceutical companies, scientific research institutions, government agencies, and other organizations involved in the life science industry.

Featured Articles

Earnings History and Estimates for Healthpeak Properties (NYSE:PEAK)

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.